Wolverine Trading, LLC Durect Corp Put Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2020 Nov 13, 2020	SELL	$1.6 - $2.35 $24,000 - $35,250	-15,000 Reduced 49.34%	15,400 $27,000
Q2 2020 Aug 13, 2020	SELL	$1.33 - $2.76 $20,615 - $42,780	-15,500 Reduced 33.77%	30,400 $76,000
Q1 2020 May 11, 2020	SELL	$0.97 - $2.85 $5,335 - $15,675	-5,500 Reduced 10.7%	45,900 $69,000
Q4 2019 Feb 12, 2020	BUY	$1.69 - $3.8 $62,699 - $140,980	37,100 Added 259.44%	51,400 $181,000
Q3 2019 Nov 14, 2019	BUY	$0.61 - $2.21 $8,723 - $31,603	14,300 New	14,300 $28,000

593K

Ticker DRRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 227,794,000
Market Cap $230M
Description
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogeno...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.